Anticoagulation in childhood-onset arterial ischemic stroke with nonmoyamoya arteriopathy: Findings from the Colorado and German (COAG) collaboration

Stroke

Volumn 40, Issue 8, 2009, Pages 2869-2871

  Bernard, Timothy J ^a,b   Goldenberg, Neil A ^a,b   Tripputi, Mark ^b   Manco Johnson, Marilyn J ^a,b   Niederstadt, Thomas ^c,d   Nowak Göttl, Ulrike ^c,d  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Anticoagulation; Arteriopathy; Childhood stroke

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADOLESCENT; ANTICOAGULATION; ARTERY DISEASE; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINUOUS INFUSION; DRUG SAFETY; HEMATOMA; HUMAN; INFANT; MENORRHAGIA; ONSET AGE; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBRAL ARTERIAL DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLORADO; GERMANY; HUMANS; INFANT; MOYAMOYA DISEASE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 68749105923     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.550699     Document Type: Article

References (9)

1. Goldenberg NA, Bernard TJ, Gordon A, Fullerton H, DeVeber G. Acute treatments and early outcomes of childhood arterial ischemic stroke: first analysis of the International Pediatric Stroke Study. Blood. 2008;112: 1978A.
2. deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000;15:316-324.
3. Fullerton HJ, Wu YW, Sidney S, Johnston SC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics. 2007;119:495-501.
4. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, DeVeber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM, Smith ER. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39:2644-2691.
5. Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, Kurnik K, Schobess R, Nowak-Göttl U. Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet. 2002;360:1540-1545.
6. Sebire G, Fullerton H, Riou E, DeVeber G. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr. 2004;16:617-622.
7. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
8. Sträter R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Göttl U. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke. 2001;32:2554-2558.
9. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, DeVeber G, Leaker M, Chan AK, Massicotte MP. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr. 2000;136:439-445.